158 related articles for article (PubMed ID: 17872471)
1. Linking calsequestrin to lumenal control of SR Ca2+ release.
Shannon TR
Circ Res; 2007 Sep; 101(6):539-41. PubMed ID: 17872471
[No Abstract] [Full Text] [Related]
2. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
[TBL] [Abstract][Full Text] [Related]
3. Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
Faber GM; Rudy Y
Cardiovasc Res; 2007 Jul; 75(1):79-88. PubMed ID: 17531962
[TBL] [Abstract][Full Text] [Related]
4. A calcium-induced calcium release mechanism mediated by calsequestrin.
Lee YS; Keener JP
J Theor Biol; 2008 Aug; 253(4):668-79. PubMed ID: 18538346
[TBL] [Abstract][Full Text] [Related]
5. Catecholaminergic polymorphic ventricular tachycardia: recent mechanistic insights.
Kontula K; Laitinen PJ; Lehtonen A; Toivonen L; Viitasalo M; Swan H
Cardiovasc Res; 2005 Aug; 67(3):379-87. PubMed ID: 15913575
[TBL] [Abstract][Full Text] [Related]
6. Conditional FKBP12.6 overexpression in mouse cardiac myocytes prevents triggered ventricular tachycardia through specific alterations in excitation-contraction coupling.
Gellen B; Fernández-Velasco M; Briec F; Vinet L; LeQuang K; Rouet-Benzineb P; Bénitah JP; Pezet M; Palais G; Pellegrin N; Zhang A; Perrier R; Escoubet B; Marniquet X; Richard S; Jaisser F; Gómez AM; Charpentier F; Mercadier JJ
Circulation; 2008 Apr; 117(14):1778-86. PubMed ID: 18378612
[TBL] [Abstract][Full Text] [Related]
7. Cellular mechanism of calcium-mediated triggered activity in the heart.
Katra RP; Laurita KR
Circ Res; 2005 Mar; 96(5):535-42. PubMed ID: 15718502
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.
Kalyanasundaram A; Viatchenko-Karpinski S; Belevych AE; Lacombe VA; Hwang HS; Knollmann BC; Gyorke S; Periasamy M
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H253-61. PubMed ID: 21984545
[TBL] [Abstract][Full Text] [Related]
9. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Dirksen WP; Lacombe VA; Chi M; Kalyanasundaram A; Viatchenko-Karpinski S; Terentyev D; Zhou Z; Vedamoorthyrao S; Li N; Chiamvimonvat N; Carnes CA; Franzini-Armstrong C; Györke S; Periasamy M
Cardiovasc Res; 2007 Jul; 75(1):69-78. PubMed ID: 17449018
[TBL] [Abstract][Full Text] [Related]
10. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
[TBL] [Abstract][Full Text] [Related]
11. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
[TBL] [Abstract][Full Text] [Related]
12. Catecholaminergic polymorphic ventricular tachycardia from bedside to bench and beyond.
Katz G; Arad M; Eldar M
Curr Probl Cardiol; 2009 Jan; 34(1):9-43. PubMed ID: 19068246
[TBL] [Abstract][Full Text] [Related]
13. Gain and cardiac E-C coupling: revisited and revised.
Wier WG
Circ Res; 2007 Sep; 101(6):533-5. PubMed ID: 17872469
[No Abstract] [Full Text] [Related]
14. Egr-1 negatively regulates calsequestrin expression and calcium dynamics in ventricular cells.
Kasneci A; Kemeny-Suss NM; Komarova SV; Chalifour LE
Cardiovasc Res; 2009 Mar; 81(4):695-702. PubMed ID: 19103607
[TBL] [Abstract][Full Text] [Related]
15. [Function and role of the sarcoplasmic reticulum in heart disease].
Reyes-Juárez JL; Zarain-Herzberg A
Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
[TBL] [Abstract][Full Text] [Related]
16. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia.
Knollmann BC; Chopra N; Hlaing T; Akin B; Yang T; Ettensohn K; Knollmann BE; Horton KD; Weissman NJ; Holinstat I; Zhang W; Roden DM; Jones LR; Franzini-Armstrong C; Pfeifer K
J Clin Invest; 2006 Sep; 116(9):2510-20. PubMed ID: 16932808
[TBL] [Abstract][Full Text] [Related]
17. Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.
Faggioni M; Kryshtal DO; Knollmann BC
Pediatr Cardiol; 2012 Aug; 33(6):959-67. PubMed ID: 22421959
[TBL] [Abstract][Full Text] [Related]
18. Triadin: the new player on excitation-contraction coupling block.
Morad M; Cleemann L; Knollmann BC
Circ Res; 2005 Apr; 96(6):607-9. PubMed ID: 15802617
[No Abstract] [Full Text] [Related]
19. Letter to the editor: Re-evaluation of heart failure in transgenic mice with impaired SR Ca2+ release.
Sato Y; Schmidt AG; Kiriazis H; Hoit BD; Kranias EG
J Mol Cell Cardiol; 2001 Sep; 33(9):1757-9. PubMed ID: 11549354
[No Abstract] [Full Text] [Related]
20. Ablation of HRC alleviates cardiac arrhythmia and improves abnormal Ca handling in CASQ2 knockout mice prone to CPVT.
Liu B; Ho HT; Brunello L; Unudurthi SD; Lou Q; Belevych AE; Qian L; Kim DH; Cho C; Janssen PM; Hund TJ; Knollmann BC; Kranias EG; Györke S
Cardiovasc Res; 2015 Nov; 108(2):299-311. PubMed ID: 26410369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
